Esophageal and esophagogastric junction cancers, Version 1.2015

Jaffer A. Ajani, Thomas A. D'Amico, Khaldoun Almhanna, David J. Bentrem, Stephen Besh, Joseph Chao, Prajnan Das, Crystal Denlinger, Paul Fanta, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Steven Hochwald, Wayne L. Hofstetter, David H. Ilson, Dawn Jaroszewski, Kory Jasperson, Rajesh N. Keswani, Lawrence R. KleinbergW. Michael Korn, Stephen Leong, A. Craig Lockhart, Mary F. Mulcahy, Mark B. Orringer, James A. Posey, George A. Poultsides, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese, Mary Kay Washington, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole McMillian, Hema Sundar

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries, originating mostly in the lower third of the esophagus, which often involves the esophagogastric junction (EGJ). Recent randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival in patients with resectable cancer. Targeted therapies with trastuzumab and ramucirumab have produced encouraging results in the treatment of advanced or metastatic EGJ adenocarcinomas. Multidisciplinary team management is essential for patients with esophageal and EGJ cancers. This portion of the NCCN Guidelines for Esophageal and EGJ Cancers discusses management of locally advanced adenocarcinoma of the esophagus and EGJ.

Original languageEnglish (US)
Pages (from-to)194-227
Number of pages34
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number2
StatePublished - Feb 1 2015

Fingerprint

Esophagogastric Junction
Neoplasms
Adenocarcinoma
Esophageal Neoplasms
North America
Esophagus
Cause of Death
Guidelines
Drug Therapy
Survival
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Besh, S., Chao, J., ... Sundar, H. (2015). Esophageal and esophagogastric junction cancers, Version 1.2015. JNCCN Journal of the National Comprehensive Cancer Network, 13(2), 194-227.

Esophageal and esophagogastric junction cancers, Version 1.2015. / Ajani, Jaffer A.; D'Amico, Thomas A.; Almhanna, Khaldoun; Bentrem, David J.; Besh, Stephen; Chao, Joseph; Das, Prajnan; Denlinger, Crystal; Fanta, Paul; Fuchs, Charles S.; Gerdes, Hans; Glasgow, Robert E.; Hayman, James A.; Hochwald, Steven; Hofstetter, Wayne L.; Ilson, David H.; Jaroszewski, Dawn; Jasperson, Kory; Keswani, Rajesh N.; Kleinberg, Lawrence R.; Korn, W. Michael; Leong, Stephen; Lockhart, A. Craig; Mulcahy, Mary F.; Orringer, Mark B.; Posey, James A.; Poultsides, George A.; Sasson, Aaron R.; Scott, Walter J.; Strong, Vivian E.; Varghese, Thomas K.; Washington, Mary Kay; Willett, Christopher G.; Wright, Cameron D.; Zelman, Debra; McMillian, Nicole; Sundar, Hema.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 2, 01.02.2015, p. 194-227.

Research output: Contribution to journalArticle

Ajani, JA, D'Amico, TA, Almhanna, K, Bentrem, DJ, Besh, S, Chao, J, Das, P, Denlinger, C, Fanta, P, Fuchs, CS, Gerdes, H, Glasgow, RE, Hayman, JA, Hochwald, S, Hofstetter, WL, Ilson, DH, Jaroszewski, D, Jasperson, K, Keswani, RN, Kleinberg, LR, Korn, WM, Leong, S, Lockhart, AC, Mulcahy, MF, Orringer, MB, Posey, JA, Poultsides, GA, Sasson, AR, Scott, WJ, Strong, VE, Varghese, TK, Washington, MK, Willett, CG, Wright, CD, Zelman, D, McMillian, N & Sundar, H 2015, 'Esophageal and esophagogastric junction cancers, Version 1.2015', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 2, pp. 194-227.
Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J et al. Esophageal and esophagogastric junction cancers, Version 1.2015. JNCCN Journal of the National Comprehensive Cancer Network. 2015 Feb 1;13(2):194-227.
Ajani, Jaffer A. ; D'Amico, Thomas A. ; Almhanna, Khaldoun ; Bentrem, David J. ; Besh, Stephen ; Chao, Joseph ; Das, Prajnan ; Denlinger, Crystal ; Fanta, Paul ; Fuchs, Charles S. ; Gerdes, Hans ; Glasgow, Robert E. ; Hayman, James A. ; Hochwald, Steven ; Hofstetter, Wayne L. ; Ilson, David H. ; Jaroszewski, Dawn ; Jasperson, Kory ; Keswani, Rajesh N. ; Kleinberg, Lawrence R. ; Korn, W. Michael ; Leong, Stephen ; Lockhart, A. Craig ; Mulcahy, Mary F. ; Orringer, Mark B. ; Posey, James A. ; Poultsides, George A. ; Sasson, Aaron R. ; Scott, Walter J. ; Strong, Vivian E. ; Varghese, Thomas K. ; Washington, Mary Kay ; Willett, Christopher G. ; Wright, Cameron D. ; Zelman, Debra ; McMillian, Nicole ; Sundar, Hema. / Esophageal and esophagogastric junction cancers, Version 1.2015. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 2. pp. 194-227.
@article{32efa6992f08434da8dd28d91b4439c5,
title = "Esophageal and esophagogastric junction cancers, Version 1.2015",
abstract = "Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries, originating mostly in the lower third of the esophagus, which often involves the esophagogastric junction (EGJ). Recent randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival in patients with resectable cancer. Targeted therapies with trastuzumab and ramucirumab have produced encouraging results in the treatment of advanced or metastatic EGJ adenocarcinomas. Multidisciplinary team management is essential for patients with esophageal and EGJ cancers. This portion of the NCCN Guidelines for Esophageal and EGJ Cancers discusses management of locally advanced adenocarcinoma of the esophagus and EGJ.",
author = "Ajani, {Jaffer A.} and D'Amico, {Thomas A.} and Khaldoun Almhanna and Bentrem, {David J.} and Stephen Besh and Joseph Chao and Prajnan Das and Crystal Denlinger and Paul Fanta and Fuchs, {Charles S.} and Hans Gerdes and Glasgow, {Robert E.} and Hayman, {James A.} and Steven Hochwald and Hofstetter, {Wayne L.} and Ilson, {David H.} and Dawn Jaroszewski and Kory Jasperson and Keswani, {Rajesh N.} and Kleinberg, {Lawrence R.} and Korn, {W. Michael} and Stephen Leong and Lockhart, {A. Craig} and Mulcahy, {Mary F.} and Orringer, {Mark B.} and Posey, {James A.} and Poultsides, {George A.} and Sasson, {Aaron R.} and Scott, {Walter J.} and Strong, {Vivian E.} and Varghese, {Thomas K.} and Washington, {Mary Kay} and Willett, {Christopher G.} and Wright, {Cameron D.} and Debra Zelman and Nicole McMillian and Hema Sundar",
year = "2015",
month = "2",
day = "1",
language = "English (US)",
volume = "13",
pages = "194--227",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Esophageal and esophagogastric junction cancers, Version 1.2015

AU - Ajani, Jaffer A.

AU - D'Amico, Thomas A.

AU - Almhanna, Khaldoun

AU - Bentrem, David J.

AU - Besh, Stephen

AU - Chao, Joseph

AU - Das, Prajnan

AU - Denlinger, Crystal

AU - Fanta, Paul

AU - Fuchs, Charles S.

AU - Gerdes, Hans

AU - Glasgow, Robert E.

AU - Hayman, James A.

AU - Hochwald, Steven

AU - Hofstetter, Wayne L.

AU - Ilson, David H.

AU - Jaroszewski, Dawn

AU - Jasperson, Kory

AU - Keswani, Rajesh N.

AU - Kleinberg, Lawrence R.

AU - Korn, W. Michael

AU - Leong, Stephen

AU - Lockhart, A. Craig

AU - Mulcahy, Mary F.

AU - Orringer, Mark B.

AU - Posey, James A.

AU - Poultsides, George A.

AU - Sasson, Aaron R.

AU - Scott, Walter J.

AU - Strong, Vivian E.

AU - Varghese, Thomas K.

AU - Washington, Mary Kay

AU - Willett, Christopher G.

AU - Wright, Cameron D.

AU - Zelman, Debra

AU - McMillian, Nicole

AU - Sundar, Hema

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries, originating mostly in the lower third of the esophagus, which often involves the esophagogastric junction (EGJ). Recent randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival in patients with resectable cancer. Targeted therapies with trastuzumab and ramucirumab have produced encouraging results in the treatment of advanced or metastatic EGJ adenocarcinomas. Multidisciplinary team management is essential for patients with esophageal and EGJ cancers. This portion of the NCCN Guidelines for Esophageal and EGJ Cancers discusses management of locally advanced adenocarcinoma of the esophagus and EGJ.

AB - Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries, originating mostly in the lower third of the esophagus, which often involves the esophagogastric junction (EGJ). Recent randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival in patients with resectable cancer. Targeted therapies with trastuzumab and ramucirumab have produced encouraging results in the treatment of advanced or metastatic EGJ adenocarcinomas. Multidisciplinary team management is essential for patients with esophageal and EGJ cancers. This portion of the NCCN Guidelines for Esophageal and EGJ Cancers discusses management of locally advanced adenocarcinoma of the esophagus and EGJ.

UR - http://www.scopus.com/inward/record.url?scp=84923460712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923460712&partnerID=8YFLogxK

M3 - Article

C2 - 25691612

AN - SCOPUS:84923460712

VL - 13

SP - 194

EP - 227

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 2

ER -